The Man Who Sued Facebook Is Bullish About the Platform
*By Conor White*
Though he sued Mark Zuckerberg for stealing the idea for Facebook, Divya Narendra said he's excited about the future of the social media giant, and sees Facebook as a good investment.
"If you have a long-term mindset, this is probably one of the cheapest stocks you can own," said Narendra in an interview Thursday with Cheddar's Kristen Scholer and Brad Smith. "On a price-to-earnings basis, or on a price-to-growth basis, really versus any other stock in this sort of large cap universe."
Narendra hit Zuckerberg with an intellectual property suit for allegedly stealing the idea for Facebook while the two were students at Harvard. They settled in 2009 for around $65 million ー $20 million in cash and 1.25 million Facebook shares. Despite that antagonistic history, Narendra is bullish on Zuckerberg's company.
"You saw a 15 to 20 percent drop in the stock off of bad PR, which is I think a solvable problem," said Narendra. "I guess that's how the markets work, but clearly an overreaction."
Narendra is the chief executive of SumZero, an investment website for professional investors.
For the full interview, [click here](https://cheddar.com/videos/facebook-looks-to-future-after-beating-earnings-expectations).
A group of Democratic Texas lawmakers is asking Elon Musk to delay his rollout of driverless ‘robotaxis’ in the state this weekend to assure the vehicles are safe enough.
The billionaire slated to takeover the controlling interest in the Los Angeles Lakers has built a career leading businesses investing in everything from sports franchises to artificial intelligence.
IBM Fellow Jerry Chow talks IBM’s expansion of the Quantum Data Center in Poughkeepsie, installing Heron processors that deliver utility‑scale performance.
Ken Shepard, Head of Specialty Asset Management at Bank of America, discusses the importance of real assets and unpacks the bank's specialty asset outlook.
Cardinal Health's Debbie Weitzman explains how the company's Advanced Therapy Solutions Innovation Center aims to improve access to specialty medicines. Watch!
